Patents by Inventor Matthew Eugene Pokross

Matthew Eugene Pokross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8512972
    Abstract: The crystal structure of ligand-bound EGLN1 catalytic domain of prolyl hydroxylase is disclosed. These coordinates are useful in computer aided drug design for identifying compounds that regulate EGLN1 prolyl hydroxylase and thereby regulate HIF-regulated disorders.
    Type: Grant
    Filed: September 12, 2011
    Date of Patent: August 20, 2013
    Assignee: Akebia Therapeutics, Inc.
    Inventors: Artem Gennady Evdokimov, Richard Masaru Kawamoto, Angelique Sun Boyer, Marlene Jan Mekel, Matthew Eugene Pokross, Richard Lee Walter, Jr.
  • Publication number: 20120282627
    Abstract: The crystal structure of ligand-bound EGLN1 catalytic domain of prolyl hydroxylase is disclosed. These coordinates are useful in computer aided drug design for identifying compounds that regulate EGLN1 prolyl hydroxylase and thereby regulate HIF-regulated disorders.
    Type: Application
    Filed: September 12, 2011
    Publication date: November 8, 2012
    Inventors: Artem Gennady Evdokimov, Richard Masaru Kawamoto, Angelique Sun Boyer, Marlene Jan Mekel, Matthew Eugene Pokross, Richard Lee Walter, JR.
  • Patent number: 8050873
    Abstract: The crystal structure of ligand-bound EGLN1 catalytic domain of prolyl hydroxylase is disclosed. These coordinates are useful in computer aided drug design for identifying compounds that regulate EGLN1 prolyl hydroxylase and thereby regulate HIF-regulated disorders.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: November 1, 2011
    Assignee: Warner Chilcott Company
    Inventors: Artem Gennady Evdokimov, Richard Masaru Kawamoto, Angelique Sun Boyer, Marlene Jan Mekel, Matthew Eugene Pokross, Richard Lee Walter, Jr.
  • Patent number: 7769575
    Abstract: The crystal structures of catalytic domain of HPTPbeta, both ligand-bound and ligand-free are described. These structures are useful in computer aided drug design for identifying compounds that bind or activate HPTPbeta and thereby modulate angiogenesis mediated disorders or diseases.
    Type: Grant
    Filed: March 23, 2009
    Date of Patent: August 3, 2010
    Assignee: Warner Chilcott, LLC
    Inventors: Artem Gennady Evdokimov, Matthew Eugene Pokross
  • Publication number: 20100030487
    Abstract: The crystal structures of catalytic domain of HPTPbeta, both ligand-bound and ligand-free are described. These structures are useful in computer aided drug design for identifying compounds that bind or activate HPTPbeta and thereby modulate angiogenesis mediated disorders or diseases.
    Type: Application
    Filed: March 23, 2009
    Publication date: February 4, 2010
    Inventors: Artem Gennady Evdokimov, Matthew Eugene Pokross
  • Patent number: 7588924
    Abstract: The crystal structure of ligand-bound EGLN1 catalytic domain of prolyl hydroxylase is disclosed. These coordinates are useful in computer aided drug design for identifying compounds that regulate EGLN1 prolyl hydroxylase and thereby regulate HIF-regulated disorders.
    Type: Grant
    Filed: March 5, 2007
    Date of Patent: September 15, 2009
    Assignee: Procter & Gamble Company
    Inventors: Artem Gennady Evdokimov, Richard Masaru Kawamoto, Angelique Sun Boyer, Marlene Jan Mekel, Matthew Eugene Pokross, Richard Lee Walter, Jr.
  • Patent number: 7507568
    Abstract: The crystal structures of catalytic domain of HPTPbeta, both ligand-bound and ligan-free are described. These structures are useful in computer aided drug design for identifying compounds that bind or activate HPTPbeta and thereby modulate angiogenesis mediated disorders or diseases.
    Type: Grant
    Filed: August 4, 2003
    Date of Patent: March 24, 2009
    Assignee: The Proctor & Gamble Company
    Inventors: Artem Gennady Evdokimov, Matthew Eugene Pokross
  • Publication number: 20080124740
    Abstract: The crystal structure of ligand-bound EGLN1 catalytic domain of prolyl hydroxylase is disclosed. These coordinates are useful in computer aided drug design for identifying compounds that regulate EGLN1 prolyl hydroxylase and thereby regulate HIF-regulated disorders.
    Type: Application
    Filed: March 5, 2007
    Publication date: May 29, 2008
    Inventors: Artem Gennady Evdokimov, Richard Masaru Kawamoto, Angelique Sun Boyer, Marlene Jan Mekel, Matthew Eugene Pokross, Richard Lee Walter
  • Publication number: 20040167183
    Abstract: Compounds of formula (I): 1
    Type: Application
    Filed: August 4, 2003
    Publication date: August 26, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Sean Rees Klopfenstein, Matthew Brian Maier, David Robert Jones, Jeffrey Lyle Gray, Matthew Eugene Pokross, Kevin Gene Peters, Artem Gennady Evdokimov
  • Publication number: 20040077065
    Abstract: The crystal structures of catalytic domain of HPTPbeta, both ligand-bound and ligan-free are described. These structures are useful in computer aided drug design for identifying compounds that bind or activate HPTPbeta and thereby modulate angiogenesis mediated disorders or diseases.
    Type: Application
    Filed: August 4, 2003
    Publication date: April 22, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Artem Gennady Evdokimov, Matthew Eugene Pokross